
|Articles|May 15, 2006
Keratoprosthesis offers many advantages in cases of pediatriccorneal opacity
An impressive track record with the Dohlman-Doane Bostonkeratoprosthesis in adults at high risk for corneal transplantationhas motivated corneal surgeons to use the device in pediatric eyeswith corneal opacities, and the outcomes in those young patientshave been very encouraging.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Glaukos receives FDA approval for Epioxa topical therapy for keratoconus
2
Dompé's NAION program selected for FDA Commissioner’s National Priority Voucher Program
3
Aurion Biotech releases positive 12-month results from phase 1/2 CLARA trial
4
AAO 2025: Diana Do, MD, reviews the real-world use of aflibercept 8 mg
5